# Effect of Corticosteroid Treatment on Prognosis in ARDS Secondary to Covid-19

> **NCT04586114** · — · UNKNOWN · sponsor: **Central Hospital, Nancy, France** · enrollment: 200 (actual)

## Conditions studied

- Acute Respiratory Distress Syndrome Secondary to Covid-19

## Interventions

- **DRUG:** Corticosteroids and Derivatives

## Key facts

- **NCT ID:** NCT04586114
- **Lead sponsor:** Central Hospital, Nancy, France
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-03-01
- **Primary completion:** 2020-05-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2020-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04586114

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04586114, "Effect of Corticosteroid Treatment on Prognosis in ARDS Secondary to Covid-19". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04586114. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*